Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-YsEcG9c4
March 17, 2023jessica-sacher
Biotech news Clinical trials

Armata Pharmaceuticals announces positive topline data from the completed Phase 1b2a SWARM-P.a. trial evaluating AP-PA02, a novel, inhaled multi-phage therapeutic for the treatment of chronic pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients.

Loading ...
No comments yet. Be the first to comment!